Clinical Trial Update: LMB-2 to Treat Hairy Cell Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial update for LMB-2 in hairy cell leukemia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hairy Cell Leukemia

Drugs mentioned

• LMB-2

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hairy Cell Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-04-05